Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice. 1987

Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori

The antitumor activities, resulting from the combined treatment of leukocyte interferon (IFN-alpha), with recombinant human immune interferon (IFN-gamma), against human tumor xenografts in nude mice, were studied. Nine human tumor xenografts, (7 from gastric carcinoma, 1 from gallbladder carcinoma and 1 from breast carcinoma), were serially transplanted into nude mice for the purpose of this experiment. Each human tumor xenograft was inoculated subcutaneously into BALB/c nu/nu nude mice and treatment was started after the estimated tumor had reached 100-300 mg. IFN was administered intramuscularly at a schedule of qd X 14. Treatment with either IFN-alpha or IFN-gamma alone, did not produce any antitumor effect against the various human tumor xenografts, however the combination of IFN-alpha with IFN-gamma resulted in achieving significant antitumor effects against the various human tumors. Inhibition of tumor growth was observed in 7 of the 9 tumors (77.8 per cent), and regression of the tumor was noted in 5 of the 9 tumors (55.6 per cent).

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
January 1987, Acta obstetricia et gynecologica Scandinavica,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
December 1988, The Keio journal of medicine,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
January 1998, Anticancer research,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
July 1985, British journal of cancer,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
May 1984, Igaku kenkyu. Acta medica,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
February 1997, Journal of surgical oncology,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
January 1986, Japanese journal of cancer research : Gann,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
August 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
April 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Nosoh, and T Toge, and K Niimi, and M Nishiyama, and N Hirabayashi, and K Nakanishi, and M Niimoto, and T Hattori
December 1990, Nihon Gan Chiryo Gakkai shi,
Copied contents to your clipboard!